KKR sets aside $200 mn for its India medical devices bet

The PE giant aims to acquire more assets to scale up medical devices maker Healthium

- Priyamvada C. & Sneha Shah

KKR had acquired Healthium for about ₹7,000 crore last year.

Global private equity giant KKR has earmarked $150-200 million to acquire assets to scale up medical devices maker Healthium MedTech, according to three people familiar with the matter, as it continues to scout for healthcare bets in India.

The firm has been proactively scouting for scalable and profitable assets it can merge under Healthium—acquired last year for about ₹7,000 crore—as a bolt-on strategy and has allocated capital and resources for this, the people cited above said, speaking on the condition of anonymity.

The company also has the firepower to invest significantly more if opportunities arise, one of the people cited above said, adding that the private equity firm is keen on expanding its product portfolio and entering new therapy areas, such as cardiology, orthopaedics, and diagnostics.